These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates. García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G, Foulds KE, McDermott A, Kao SF, Roederer M, Hawkins N, Self S, Yao J, Farrell P, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo A, Weiss D, Lee C, Kibler K, Jacobs B, Asbach B, Wagner R, Ding S, Pantaleo G, Esteban M. J Virol; 2015 Aug; 89(16):8525-39. PubMed ID: 26041302 [Abstract] [Full Text] [Related]
25. HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice. Jongwe TI, Chapman R, Douglass N, Chetty S, Chege G, Williamson AL. PLoS One; 2016 Aug; 11(7):e0159141. PubMed ID: 27427967 [Abstract] [Full Text] [Related]
26. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge. Li Z, Zhang M, Zhou C, Zhao X, Iijima N, Frankel FR. J Immunol; 2008 Feb 15; 180(4):2504-13. PubMed ID: 18250460 [Abstract] [Full Text] [Related]
31. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. Gupta S, Termini JM, Raffa FN, Williams CA, Kornbluth RS, Stone GW. J Virol; 2014 Feb 15; 88(3):1492-501. PubMed ID: 24227853 [Abstract] [Full Text] [Related]
33. DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination. Hu X, Valentin A, Cai Y, Dayton F, Rosati M, Ramírez-Salazar EG, Kulkarni V, Broderick KE, Sardesai NY, Wyatt LS, Earl PL, Moss B, Mullins JI, Pavlakis GN, Felber BK. Hum Gene Ther; 2018 Sep 15; 29(9):1029-1043. PubMed ID: 29869530 [Abstract] [Full Text] [Related]
39. Prime-boost immunization of codon optimized HIV-1 CRF01_AE Gag in BCG with recombinant vaccinia virus elicits MHC class I and II immune responses in mice. Promkhatkaew D, Pinyosukhee N, Thongdeejaroen W, Teeka J, Wutthinantiwong P, Leangaramgul P, Sawanpanyalert P, Warachit P. Immunol Invest; 2009 Sep 15; 38(8):762-79. PubMed ID: 19860587 [Abstract] [Full Text] [Related]
40. Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost. Virnik K, Nesti E, Dail C, Scanlan A, Medvedev A, Vassell R, McGuire AT, Stamatatos L, Berkower I. Vaccine; 2018 Aug 16; 36(34):5166-5172. PubMed ID: 30037665 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]